Bifida yeast culture medium, Bifida yeast fermentation liquid, and preparation method and application thereof

By using specific composition difibrillar yeast culture medium and anaerobic conditions, the DPPH clearance rate and anti-wrinkle and skin firming effect of the fermentation broth are significantly improved, and the free radicals of the fermentation broth in the prior art are solved. The problem of insufficient removal ability is suitable for the preparation of cosmetics.

CN116656563BActive Publication Date: 2024-11-15SHENZHEN SANDA COSMETICS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310708760.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-06-14
Publication Date
2024-11-15
Estimated Expiration
2043-06-14

AI Technical Summary

Technical Problem

The free radical scavenging ability of the existing difibrillar yeast fermentation broth is insufficient and cannot be effectively applied to cosmetics production.

Method used

Using a specific composition of difibrillated yeast culture medium, including nitrogen, carbon, histidine, dipotassium hydrogen phosphate, magnesium chloride, calcium chloride, manganese sulfate, sodium acetate and L-cysteine, under anaerobic conditions Cultivate difibrillar yeast to increase its viable bacterial count and OD value, and significantly increase the clearance rate of DPPH in the fermentation broth.

Benefits of technology

It significantly improves the DPPH clearance of difibrillar yeast fermentation broth, has excellent anti-wrinkle, firming and soothing skin effects, and is suitable for the preparation of anti-aging cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004287009680000071
    Figure BDA0004287009680000071
  • Figure BDA0004287009680000081
    Figure BDA0004287009680000081
  • Figure BDA0004287009680000091
    Figure BDA0004287009680000091
Patent Text Reader

Abstract

The invention discloses a bifid yeast culture medium, a bifid yeast fermentation liquid, and a preparation method and application thereof, and belongs to the technical field of cosmetics; bifid yeast is cultured using the bifid yeast culture medium provided by the invention, and the obtained bifid yeast fermentation liquid has excellent DPPH removal effect, and has significant anti-wrinkle, skin tightening, and skin soothing effects. At the same time, the components of the bifid yeast culture medium provided by the invention are conventional and easy to obtain, and the preparation method of the bifid yeast fermentation liquid is simple to operate, which is conducive to actual production and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of cosmetics, and in particular relates to a bifid yeast culture medium, a bifid yeast fermentation liquid, and a preparation method and application thereof. Background Art

[0002] Bifidobacterium is a bifidobacterium obtained by decomposing active cells. It contains vitamins, amino acids and minerals that nourish cells. The filtrate of its fermentation product can be used in skin care products to enhance skin metabolism, promote cell proliferation, tighten the skin, reduce fine lines, and has good wrinkle-removing and firming effects.

[0003] The algae of Ulva are rich in active substances such as algae polysaccharides, amino acids, unsaturated fatty acids, vitamins, trace elements and ketones. Its extracts have unique biocompatibility, good moisturizing, antioxidant, anti-aging, whitening and anti-wrinkle, antibacterial and anti-inflammatory effects.

[0004] Although the current research on Bifida yeast fermentation broth has been found to have a certain effect of scavenging free radicals, its scavenging ability is obviously insufficient and cannot be effectively applied to the actual cosmetic production. Therefore, how to prepare Bifida yeast fermentation broth with excellent free radical scavenging rate is a current research hotspot. Summary of the invention

[0005] The purpose of the present invention is to overcome the shortcomings of the above-mentioned prior art and provide a bifid yeast culture medium, a bifid yeast fermentation liquid and a preparation method and application thereof.

[0006] To achieve the above-mentioned object, in a first aspect of the present invention, the present invention provides a bifid yeast culture medium, the culture medium comprising the following components in parts by weight: 0.5-5 parts of a nitrogen source, 1-4 parts of a carbon source, 0.005-0.04 parts of histidine, 0.05-0.4 parts of dipotassium hydrogen phosphate, 0.01-0.1 parts of magnesium chloride, 0.005-0.03 parts of calcium chloride, 0.001-0.01 parts of manganese sulfate, 0.1-1 parts of sodium acetate, 0.01-0.1 parts of L-cysteine, and 70-99 parts of water; the nitrogen source is acid hydrolyzed casein; and the carbon source is at least one of ulva polysaccharide and ulva powder.

[0007] The inventors have found that by adopting the culture medium of the present invention, the bifid yeast can be better proliferated in the subsequent bifid yeast culture process, the total number of viable bacteria obtained is greater, and the OD value is also higher; at the same time, the bifid yeast fermentation liquid obtained after culture has a higher DPPH clearance rate.

[0008] As a preferred embodiment of the culture medium of the present invention, the carbon source is Ulva polysaccharide.

[0009] The inventors have found that when the selected carbon source is at least one of Ulva polysaccharide and Ulva powder, the total number of viable bacteria and the OD value can be significantly improved compared with the blank culture medium. When the carbon source is further selected as Ulva polysaccharide, the total number of viable bacteria after fermentation and culture in the culture medium is greater and the OD value is higher; at the same time, the fermentation liquid has a significantly increased ability to remove DPPH, that is, the overall effect is better.

[0010] As a preferred embodiment of the culture medium of the present invention, the culture medium includes the following components in parts by mass: 1.5-3 parts of a nitrogen source, 1.5-3 parts of a carbon source, 0.02 parts of histidine, 0.2 parts of dipotassium hydrogen phosphate, 0.05 parts of magnesium chloride, 0.015 parts of calcium chloride, 0.005 parts of manganese sulfate, 0.5 parts of sodium acetate, 0.05 parts of L-cysteine, and 80-99 parts of water.

[0011] As a preferred embodiment of the culture medium of the present invention, the culture medium includes the following components in parts by mass: 2 parts of a nitrogen source, 2 parts of a carbon source, 0.02 parts of histidine, 0.2 parts of dipotassium hydrogen phosphate, 0.05 parts of magnesium chloride, 0.015 parts of calcium chloride, 0.005 parts of manganese sulfate, 0.5 parts of sodium acetate, 0.05 parts of L-cysteine, and 95.16 parts of water.

[0012] The inventors have found that when the content of components in the culture medium is further selected to be within the above range, the comprehensive effect achieved is even better.

[0013] In a second aspect of the present invention, the present invention provides use of the culture medium in culturing bifid yeast.

[0014] The inventors have found that the culture medium provided by the present invention can be applied to the culture of bifid yeast, and can achieve rapid proliferation of bifid yeast. Under a specific culture period, the OD value is significantly increased compared with the blank group, and the obtained fermentation liquid has an excellent effect of scavenging DPPH, and can be applied to the preparation of subsequent cosmetics, so that the prepared cosmetics have good skin tightening, anti-wrinkle and skin soothing effects.

[0015] In a third aspect of the present invention, the present invention provides a method for preparing a bifid yeast fermentation broth, the preparation method comprising the following steps: taking the activated bifid yeast and inoculating it into the culture medium for culturing, and filtering after the culturing to obtain the bifid yeast fermentation broth.

[0016] As a preferred embodiment of the preparation method of the present invention, the culturing is carried out under anaerobic conditions at 35-39° C. for 20-48 hours.

[0017] Preferably, the activation conditions of the bifid yeast are as follows: a loop of cells is picked from a bifidobacterium slant test tube, added to 30 mL of sterilized BBL liquid culture medium, and cultured at 37° C. for 48 hours to obtain a bifidobacterium bacterial liquid.

[0018] Preferably, the inoculation amount of the activated bifid yeast is 2-4%.

[0019] The inventors have found that the preparation method provided by the present invention can achieve better culture effects and the comprehensive effects of the obtained products are better.

[0020] In a fourth aspect of the present invention, the present invention provides a bifid yeast fermentation broth, wherein the bifid yeast fermentation broth is prepared by the preparation method of the present invention.

[0021] The bifid yeast fermentation broth obtained by the preparation method of the present invention has an excellent DPPH scavenging rate and also has excellent anti-wrinkle, skin tightening and skin soothing effects.

[0022] In a fifth aspect of the present invention, the present invention provides use of the bifid yeast fermentation broth in preparing cosmetics.

[0023] Preferably, the cosmetic is an anti-aging cosmetic.

[0024] As a preferred embodiment of the application of the present invention, the anti-aging cosmetic can be any one of essence and emulsion.

[0025] The inventors have found that the bifid yeast fermentation liquid provided by the present invention can effectively remove DPPH and can significantly increase the content of type I collagen, thereby achieving good anti-wrinkle and skin tightening effects; at the same time, in a cell soothing experiment, it was found that the obtained bifid yeast fermentation liquid can significantly reduce the relative content of NO, that is, it has a significant skin soothing effect; therefore, the bifid yeast fermentation liquid provided by the present invention can be used in the preparation of anti-aging cosmetics.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] The invention discloses a bifid yeast culture medium, a bifid yeast fermentation liquid, and a preparation method and application thereof. The bifid yeast culture medium provided by the invention is used to culture bifid yeast, and the obtained bifid yeast fermentation liquid has excellent DPPH removal effect, and has obvious anti-wrinkle, skin tightening and skin soothing effects. At the same time, the components of the bifid yeast culture medium provided by the invention are conventional and easy to obtain, and the preparation method of the bifid yeast fermentation liquid is simple to operate, which is conducive to actual production application. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 This is the liquid chromatogram before and after fermentation in Effect Example 2;

[0029] Figure 2 This is a diagram showing the irritation test results in Effect Example 3. DETAILED DESCRIPTION

[0030] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0031] Example 1

[0032] The embodiment of the present invention provides a bifid yeast fermentation broth, and the preparation method of the bifid yeast fermentation broth is:

[0033] A loop of bifidobacterium cells was picked from the bifidobacterium slant test tube, added to 30 mL of sterilized BBL liquid culture medium, and cultured at 37° C. for 48 h to obtain a bifidobacterium culture solution, i.e., activated bifidobacterium yeast; then, the activated bifidobacterium yeast was inoculated into the culture medium at a rate of 3%, and anaerobically cultured at 37° C. for 26 h. After the culture was completed, the culture solution was filtered to obtain a bifidobacterium yeast fermentation solution;

[0034] Among them, anaerobic culture is cultured in an anaerobic incubator (HYQX-Ⅱ), and the formation of the anaerobic environment includes the following steps: after deoxidizer granules (unopened), desiccant, and methylene blue test paper (unopened) are placed in the operating room, two nitrogen replacements and one mixed gas replacement are performed respectively.

[0035] Determination of anaerobic environment in the operating room: Open the deoxidizer pellets in the operating room, turn on the power of the deoxidation catalyst, open the Meilan test paper, and observe the color change of the test paper. If there is no color change, it indicates that the operating room has reached an anaerobic environment.

[0036] The culture medium is composed of: 2% acid hydrolyzed casein, 2% ulva polysaccharide, 0.02% histidine, 0.2% dipotassium hydrogen phosphate, 0.05% magnesium chloride, 0.015% calcium chloride, 0.005% manganese sulfate, 0.5% sodium acetate, 0.05% L-cysteine, and the balance water.

[0037] Example 2

[0038] The embodiment of the present invention provides a bifid yeast fermentation broth, which is different from the embodiment 1 only in that ulva powder is used to replace ulva polysaccharide.

[0039] Example 3

[0040] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of Ulva polysaccharide is 1%.

[0041] Example 4

[0042] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of Ulva polysaccharide is 3%.

[0043] Example 5

[0044] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of Ulva polysaccharide is 4%.

[0045] Example 6

[0046] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of acid hydrolyzed casein is 0.5%.

[0047] Example 7

[0048] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of acid hydrolyzed casein is 1.5%.

[0049] Example 8

[0050] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the addition amount of acid hydrolyzed casein is 3%.

[0051] Example 9

[0052] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the anaerobic culture time is 20 hours.

[0053] Example 10

[0054] The embodiment of the present invention provides a bifid yeast fermentation broth, the only difference between which and the embodiment 1 is that the anaerobic culture time is 34 hours.

[0055] Comparative Example 1

[0056] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that no Ulva polysaccharide is added.

[0057] Comparative Example 2

[0058] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that acid hydrolyzed casein is not added.

[0059] Comparative Example 3

[0060] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that Spirulina powder is used instead of Ulva polysaccharide.

[0061] Comparative Example 4

[0062] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that Haematococcus pluvialis powder is used instead of Ulva polysaccharide.

[0063] Comparative Example 5

[0064] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that Chlorella powder is used instead of Ulva polysaccharide.

[0065] Comparative Example 6

[0066] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that peptone is used to replace acid hydrolyzing casein.

[0067] Comparative Example 7

[0068] The comparative example of the present invention provides a bifid yeast fermentation broth, which is different from Example 1 only in that the anaerobic culture time is 5.5 h.

[0069] Comparative Example 8

[0070] The comparative example of the present invention provides a bifid yeast fermentation broth, the only difference between which and Example 1 is that the addition amount of Ulva polysaccharide is 0.5%.

[0071] Effect Example 1

[0072] In Examples 1-10, Comparative Examples 1-8 and a blank medium (the composition of the blank medium is the composition of the medium in Example 1), the total bacterial count and the OD difference (difference with the blank) at the end of the fermentation culture were tested, and the scavenging ability of the obtained bifid yeast fermentation broth on DPPH was tested;

[0073] The test method for the total bacterial count at the end of the fermentation culture is as follows: after the fermentation culture is completed, shake well, take samples, and spread them on plates to count the total number of live bacteria;

[0074] 1. The counting of total viable bacteria includes the following steps:

[0075] 1) Dilution of bacterial solution: Use a sterile pipette to draw 1 mL of supernatant and add it to 9 mL of sterile saline. Mix well to make a 1:10 test solution. Repeat this process to make a 1:100, 1:1000, and other appropriate dilution multiples.

[0076] 2) Culture: Pipette 1 mL of dilution solution for each dilution gradient and inject it into a sterile plate. Pour the Bifidobacterium culture medium that has been melted and cooled to 50°C into the plate, about 15 mL per plate. Then rotate the plate to mix the sample and the culture medium thoroughly. After the culture medium solidifies, turn the plate over and place it in a 37°C incubator for 48 hours. Take another sterile empty plate without test solution, add about 15 mL of Bifidobacterium culture medium, and after the agar solidifies, turn the plate over and place it in a 37°C incubator for 48 hours as a blank control.

[0077] The specific colony counting method includes the following steps:

[0078] 1) Select the plates with average colony counts between 30 and 300 as the range for total colony count determination. If only one dilution has an average colony count that meets this range, the plate colony count multiplied by the dilution multiple shall prevail;

[0079] 2) If there are two dilutions, and their average colony counts are both between 30 and 300, the ratio of the two total colony counts should be used to determine the result. If the ratio is less than or equal to 2, the average should be reported. If it is greater than 2, the colony count of the plate with the lower dilution should be used as the standard.

[0080] 3) If the average colony counts of all dilutions are greater than 300, the average colony count of the highest dilution multiplied by the dilution factor shall prevail;

[0081] 4) If the average colony count of all dilutions is less than 30, the average colony count of the lowest dilution multiplied by the dilution factor shall prevail;

[0082] 5) If the average colony counts of all dilutions are not between 30 and 300, and one dilution is greater than 300 and the adjacent dilution is less than 30, the average colony count close to 30 or 300 multiplied by the dilution factor shall prevail.

[0083] 2. The test method for OD difference is: subtract the blank OD (no bacteria) value from the obtained value to get the OD difference (only the difference between adding bacteria and not adding bacteria). The specific process is: use a pipette to transfer 200 μL of the fermentation supernatant of each time period, inject it into a 96-well plate, and measure its OD600 value.

[0084] 3. The test method for DPPH scavenging ability is as follows: take the bifid yeast fermentation broth of Examples 1-10 and Comparative Examples 1-8 and the blank culture medium, dilute them 8 times, and test them according to the national standard "GB / T 39100-2020 Determination of Antioxidant Activity of Polypeptides by DPPH and ABTS Method" to obtain a 50 ppm DPPH scavenging rate; the specific process is as follows: use a pipette to draw 1.25 mL of seaweed fermentation supernatant into a 10 mL volumetric flask, add distilled water to make up to 10 mL, and shake well for use. In the experimental group, 200 μL of the test solution and 600 μL of DPPH solution were pipetted into a 2 mL disposable centrifuge tube. In the blank group, 200 μL of distilled water and 600 μL of anhydrous ethanol were pipetted into a 2 mL disposable centrifuge tube. After being mixed evenly with a vortex mixer, the mixture was reacted at room temperature in the dark for 30 min, and then centrifuged for 5 min. 180 μL of the supernatant after centrifugation was pipetted into a 96-well plate, and the absorbance was measured using an enzyme reader at a wavelength of 517 nm.

[0085] The test results are shown in Table 1;

[0086] Table 1

[0087]

[0088]

[0089] It can be seen from Table 1 that when the technical solution of the present invention is adopted, after the fermentation culture is completed, by testing the total number of viable bacteria and the OD difference, it can be found that the obtained viable bacteria count and OD difference are relatively high, wherein the OD difference is above 0.024, and the viable bacteria count is above 2.0E+08, that is, the technical solution of the present invention can significantly enhance the proliferation ability of bifid yeast; at the same time, it can be seen from the DPPH clearance rate data that the product obtained by the technical solution of the present invention has an excellent DPPH clearance rate, specifically, the obtained DPPH clearance rate is above 29.16%;

[0090] As can be seen from Example 1 and Comparative Example 1, when the carbon source Ulva polysaccharide is not added to the culture medium, the OD difference measured after the culture is completed is significantly reduced, and the DPPH clearance rate of the obtained product is also significantly reduced, compared with Example 1, it is reduced by 64.86%; As can be seen from Example 1, Example 2 and Comparative Examples 3-5, the form of the carbon source has a significant effect on the OD difference and the DPPH clearance rate. When the carbon source is not the substance selected by the present invention, compared with Example 1, the number of viable bacteria obtained at the end of the culture is significantly reduced, and the OD difference also shows a significant downward trend. At the same time, the DPPH clearance rate of the obtained product also decreases, and the decline is between 25.58-58.77%; As can be seen from Example 1, Examples 3-5 and Comparative Example 8, the amount of carbon source added will also affect the number of viable bacteria, the OD difference and the DPPH clearance rate. With the increase in the mass percentage of the carbon source, the number of viable bacteria and the OD difference show a trend of first increasing and then decreasing, and the DPPH clearance rate also shows a trend of first increasing and then maintaining a stable trend;

[0091] It can be seen from Example 1 and Comparative Example 2 that when no nitrogen source is added, the OD difference after the culture is completed is significantly decreased, and the DPPH clearance rate of the obtained product is also significantly decreased, compared with Example 1, it is decreased by 51.39%; it can be seen from Example 1 and Examples 6-8 that the amount of nitrogen source added will also affect the number of viable bacteria, OD difference and DPPH clearance rate. With the increase of the mass percentage of the nitrogen source, the number of viable bacteria, OD difference and DPPH clearance rate show a trend of first increasing and then decreasing; it can be seen from Example 1 and Comparative Example 6 that when the selected nitrogen source is not a substance in the present invention, the OD difference of the obtained product is significantly decreased, and the DPPH clearance rate of the obtained product is also significantly decreased, compared with Example 1, it is decreased by 30.69%;

[0092] It can be seen from Example 1, Examples 9-10 and Comparative Example 7 that the culture time also has an impact on the results.

[0093] Effect Example 2

[0094] Effect Example of the Invention The pH value and the reducing sugar content before and after fermentation culture in Example 1 and Comparative Example 1 were tested, wherein the reducing sugar content was tested as follows:

[0095] 1) DNS reagent preparation:

[0096] Dissolve 6.3g 3,5-dinitrosalicylic acid in 400mL distilled water, gradually add 21g sodium hydroxide, then add 182g potassium sodium tartrate tetrahydrate, 5.0g phenol, 5.0g anhydrous sodium sulfite, warm water bath (no more than 48°C), stirring continuously until the solution is clear and transparent. Make up to 1000mL with distilled water, store in a brown bottle, isolate from carbon dioxide, and let stand for 6 days before use;

[0097] 2) Glucose standard curve:

[0098] Take five colorimetric tubes, add 0, 0.1, 0.2, 0.3, 0.4 mL of glucose standard solution (1 mg / mL) and 0.5, 0.4, 0.3, 0.2, 0.1 mL of distilled water, respectively, add 0.5 mL of DNS reagent to each tube, mix well, boil in a boiling water bath for 5 min, add 4 mL of distilled water after cooling, and measure OD540;

[0099] 3) Fermentation broth sample determination:

[0100] Add 0.5 mL of fermentation liquid into a colorimetric tube, add 0.5 mL of DNS reagent and mix well, boil in a boiling water bath for 5 min, cool, add 4 mL of distilled water, and measure OD540;

[0101] 4) Content determination:

[0102] The reducing sugar content (mg) of the fermentation broth was calculated according to the standard curve;

[0103] The test results are shown in Table 2;

[0104] Table 2

[0105]

[0106] As can be seen from Table 2, the technical solution of the present invention can significantly consume reducing sugars in the culture medium, indicating that the fermentation process of bifid yeast involves obvious sugar metabolism, especially reducing sugar compounds are more involved. The pH change can be related to the change in OD value / bacterial count, which is a proof of bacterial growth and fermentation, because the fermentation process is accompanied by the acidification of the solution and the formation of more small molecular acid substances; therefore, the pH value shows a downward trend after fermentation culture;

[0107] Further analysis of the liquid phase spectrum before and after the fermentation culture in Example 1 was performed, and the results obtained were as follows: Figure 1 As shown, from Figure 1 It can be seen that by using the culture method in Example 1, the macromolecular substances are obviously transformed into small molecular substances before and after fermentation.

[0108] Effect Example 3

[0109] Effect Example of the Invention The products prepared in Examples 1-10 and Comparative Examples 1-8 were subjected to irritation tests and cytotoxicity tests.

[0110] The irritation test method is based on the chicken embryo chorioallantoic membrane test of SN / T 2329-2009 Cosmetic Eye Irritation / Corrosion;

[0111] The cytotoxicity test method is as follows: take the cell culture and inoculate it in a 96-well plate at an appropriate density, with an inoculation volume of 100 μL per well, and culture it in a carbon dioxide incubator for 24 hours. After culture, discard the culture medium in the 96-well plate, add different concentrations of the test solution, set up a blank control group and a positive control group at the same time, 100 μL / well, add 6 replicates for each concentration, and culture it in a carbon dioxide incubator for 24 hours. After the culture is completed, observe and record the cell state, discard the culture medium, wash with PBS 1-2 times, add MTT working solution, 50 μL / well, and culture it in a carbon dioxide incubator for 4 hours. Discard the culture medium, add 150 μL of DMSO to each well, shake for 10 minutes, and measure the absorbance value at 570nm with an enzyme marker, using 630nm as the reference wavelength. Calculate the cell survival rate based on the measurement results. When the cell survival rate of the sample in the 96-well plate corresponding to the concentration is ≥90%, and there is no significant difference in the morphology of the cells in the sample group and the cells in the blank group, it means that the sample has no obvious cytotoxicity at this concentration.

[0112] Cell survival rate formula: Cell survival rate (%) = OD 样品 / OD 空白 ×100%,

[0113] Where: OD 样品 —mean OD value of the sample group; OD 空白 —The mean OD value of the blank control group. ;

[0114] When the bifid yeast fermentation broth obtained in Example 1 was subjected to an irritation test, the irritation test results were as follows: Figure 2 As shown, Figure 2 A in the middle is the image recorded at 0 seconds. Figure 2 B is the image recorded at 301 seconds. Figure 2 It can be seen that the bifid yeast fermentation broth provided in Example 1 of the present invention is non-irritating; the test results of the products prepared in Examples 2-11 and Comparative Examples 1-9 are consistent with those in Example 1, and the impact results are all shown to be non-irritating;

[0115] The cytotoxicity test results of the bifid yeast fermentation broth obtained in Example 1 showed that the non-toxic concentration was 2.50%; the test results of the products prepared in Examples 2-10 and Comparative Examples 1-8 were consistent with those in Example 1.

[0116] Effect Example 4

[0117] Effect Examples of the Invention The products prepared in Examples 1-2, Comparative Examples 1-3, Comparative Examples 6-8 and blank culture medium (culture medium and blank group in Example 1) were tested for skin tightening, anti-wrinkle and soothing effects;

[0118] 1. Cell anti-wrinkle and firming test method:

[0119] 1) Cell inoculation: Human skin fibroblasts HFF-1 were inoculated into a 96-well plate at an appropriate density (the degree of confluence reached 60% 24 hours after inoculation), 100 μL per well, and cultured in a CO2 incubator for 24 hours;

[0120] 2) Administration: Discard the culture medium in the 96-well plate, dilute the test substance to 2.5% with cell culture medium and add it to the test substance wells, add culture medium containing 100 ng / mL TGFβ1 to the positive control wells (Examples 1-2, Comparative Examples 1-3, Comparative Examples 6-8 and blank culture medium), and add cell culture medium to the blank control wells (negative control), 100 μL per well. After administration, place the 96-well plate in a CO2 incubator for 24 hours;

[0121] 3) ELISA detection: After the culture is completed, the cell culture supernatant in each well is collected and detected according to the instruction manual of the human type I collagen enzyme-linked immunosorbent assay kit.

[0122] Calculation of type I collagen content: Use professional curve making software to calculate the concentration and OD of the standard in the kit. 450 The regression equation of the standard curve was calculated and the OD of the samples was 450 Substitute the value into the equation to calculate the type I collagen content of the sample. The average value of the three replicate wells in each group is taken as the final type I collagen result.

[0123] The calculation formula for the up-regulation rate of type I collagen is: up-regulation rate (%) = (T / C-1) × 100%, where: T is the average value of type I collagen content in the test substance; C is the average value of type I collagen content in the blank control.

[0124] 2. The cell soothing test method is:

[0125] 1) Cell inoculation: Mouse mononuclear macrophage leukemia cell line RAW264.7 was inoculated into a 96-well plate at an appropriate density (the degree of confluence reached 90% 24 hours after inoculation), 100 μL per well, and cultured in a CO2 incubator for 24 hours.

[0126] 2) Administration: Discard the culture medium in the 96-well plate, set up a positive control group (Example 1-2, Comparative Examples 1-3, Comparative Examples 6-8 and blank culture medium), a negative control group, and a blank control group, each with 6 duplicate wells, and add 50 μL of the test solution and LPS working solution to each well. Add 100 μL of dexamethasone sodium phosphate working solution to each well of the positive control group, add 50 μL of test culture medium and 50 μL of LPS working solution to each well of the negative control group, and add 100 μL of test culture medium to each well of the blank control group. After the addition of samples, place the 96-well plate in a CO2 incubator and culture for 24 hours.

[0127] 3) Griess test: After the culture was completed, 50 μL of cell culture supernatant was collected from each well and placed in a new 96-well plate. 50 μL of Griess solution was added to each well, mixed and reacted in the dark for 10 min, and the OD value was detected at 540 nm using an enzyme reader.

[0128] NO relative content (%) = OD sample / OD negative control group × 100%;

[0129] The test results are shown in Table 3;

[0130] Table 3

[0131]

[0132] It can be seen from Table 3 that the bifid yeast fermentation broth obtained by the preparation method of the present invention can significantly increase the content of type I collagen and reduce the relative content of NO, that is, it has excellent anti-wrinkle, skin tightening and skin soothing effects.

[0133] Finally, it should be noted that the above embodiments are intended to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention may be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A medium for bifid yeast, It is characterized in that The culture medium comprises the following components in parts by mass: 0.5-5 parts of a nitrogen source, 1-4 parts of a carbon source, 0.005-0.04 parts of histidine, 0.05-0.4 parts of dipotassium hydrogen phosphate, 0.01-0.1 parts of magnesium chloride, 0.005-0.03 parts of calcium chloride, 0.001-0.01 parts of manganese sulfate, 0.1-1 parts of sodium acetate, 0.01-0.1 parts of L-cysteine, and 70-99 parts of water; The nitrogen source is acid hydrolyzed casein peptone; the carbon source is at least one of ulva polysaccharide and ulva powder.

2. The culture medium according to claim 1, It is characterized in that The carbon source is ulva polysaccharide.

3. The culture medium according to claim 1, It is characterized in that The culture medium comprises the following components in parts by mass: 1.5-3 parts of a nitrogen source, 1.5-3 parts of a carbon source, 0.02 parts of histidine, 0.2 parts of dipotassium hydrogen phosphate, 0.05 parts of magnesium chloride, 0.015 parts of calcium chloride, 0.005 parts of manganese sulfate, 0.5 parts of sodium acetate, 0.05 parts of L-cysteine, and 80-99 parts of water.

4. The culture medium according to claim 3, It is characterized in that The culture medium includes the following components in parts by mass: 2 parts of a nitrogen source, 2 parts of a carbon source, 0.02 parts of histidine, 0.2 parts of dipotassium hydrogen phosphate, 0.05 parts of magnesium chloride, 0.015 parts of calcium chloride, 0.005 parts of manganese sulfate, 0.5 parts of sodium acetate, 0.05 parts of L-cysteine, and 95.16 parts of water.

5. Use of the culture medium according to any one of claims 1 to 4 in culturing bifid yeast.

6. A method for preparing a bifid yeast fermentation broth, It is characterized in that The preparation method comprises the following steps: taking activated bifid yeast and inoculating it into the culture medium according to any one of claims 1 to 4 for culturing, and filtering after the culturing to obtain bifid yeast fermentation liquid.

7. The preparation method according to claim 6, It is characterized in that The culture is carried out under anaerobic conditions at 35-39° C. for 20-48 hours.